Mesoblast (MESO) Stock Statistics & Valuation Metrics

Mesoblast has a market cap or net worth of $2.00B. The enterprise value is $1.78K.

Mesoblast has 129,874,820 shares outstanding. The number of shares has decreased by -2.65% in one year.

Mesoblast’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -7.30%.

The current PE Ratio of Mesoblast is ―. Mesoblast’s PEG ratio is 0.64.

In the last 12 months, Mesoblast had revenue of 120.79M and earned -57.76M in profits. Earnings per share was -0.45.

In the last 12 months, operating cash flow was -41.32M and capital expenditures -1.04M, giving a free cash flow of -42.36M billion.

Mesoblast pays an annual dividend of ―, resulting in a dividend yield of ―

Mesoblast upcoming earnings date is Mar 4, 2027, TBA (Confirmed).

Mesoblast as a current ratio of 2.43, with Debt / Equity ratio of 22.40%

In the past 12 months, Mesoblast has paid 615.74K in taxes.

Mesoblast EV to EBITDA ratio is -42.72, with an EV/FCF ratio of -40.96.

Mesoblast has $102.91M in cash and marketable securities with $127.33M in debt, giving a net cash position of -$24.42M billion.

Gross margin is 78.30%, with operating margin of -42.64%, and net profit margin of -47.82%.

The average price target for Mesoblast is $37.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy